RoyceDerm Seborrheic Dermatitis and Psoriasis Treatment cream
- Manufacturer
- RoyceDerm LLC
- Effective date
- 2026-02-14
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-01 01:49:17
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Salicylic Acid 3%
OTC - PURPOSE SECTION
Anti-Seborrheic Dermatitis, Anti-Psoriasis
DOSAGE & ADMINISTRATION SECTION
- Controls the symptom of seborrheic dermatitis and psoriasis
- Helps prevent recurrence of sink & scalp itching, irritation, redness, flaking, scaling, associated with psoriasis & seborrheic dermatitis
WARNINGS SECTION
For external use only.
OTC - ASK DOCTOR SECTION
you have a condition that covers a large area of the body.
OTC - WHEN USING SECTION
Avoid contact with eyes. If contact occurs, rinse the eyes thoroughly with water.
OTC - STOP USE SECTION
If condition worsens or does not improve after regular use of this product as directed.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
If swallowed, get medical help or contact a Poison Cntrol Center right away.
INDICATIONS & USAGE SECTION
Adults and children 12 years and older: Apply to affected areas one to four times daily or as directed by a doctor.
OTHER SAFETY INFORMATION
Store at room temperature & out of direct sunlight.
INACTIVE INGREDIENT SECTION
Water, Cetyl Alcohol, Propylene Glycol,Niacinamide, Aloe Barbadensis (Aloe Vera) Leaf Juice, Propanediol,C12-20 Alkyl Glucoside, C14-22 Alcohols, Caprylic/CapricTriglyceride, Dimethicone, Helianthus Annuus (Sunflower) SeedOil, Phenoxyethanol, Polyacrylate Crosspolymer-6, Xanthan Gum,Potassium Cetyl Phosphate, Disodium EDTA, Allantoin, Actinidia Chinensis (Kiwi) Fruit Extract, Glycerin, Arctium Lappa (GreaterBurdock) Root Extract, Camellia Sinensis (White Tea) Leaf Extract,Maltodextrin, Glycyrrhiza Glabra (Licorice) Root, Chamomilla Recutita (Matricaria) Flower Extract, Calendula Officinalis(Marigold) Flower Extract, Centella Asiatica (Gotu Kola) Extract,Ethylhexylglycerin, Triethanolamine.
OTC - QUESTIONS SECTION
Visit
www.roycederm.com
Tel +1(307)461-0958
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed RxNorm Mappings#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 85424-017-01 | RoyceDerm Seborrheic Dermatitis and Psoriasis Treatment cream | 100 g in 1 CARTON | CREAM | 100 | 1 |
Products#
Every source-derived product name is available through these pages.
- RoyceDerm Seborrheic Dermatitis and Psoriasis Treatment cream
- Salicylic Acid 3%
- WATER
- CENTELLA ASIATICA LEAF WATER
- ETHYLHEXYLGLYCERIN
- CALENDULA OFFICINALIS FLOWER
- NIACINAMIDE
- DIMETHICONE
- HELIANTHUS ANNUUS (SUNFLOWER) SEED OIL
- PROPANEDIOL
- C14-22 ALCOHOLS
- POLYACRYLATE CROSSPOLYMER-6
- ACTINIDIA CHINENSIS (KIWI) FRUIT JUICE
- XANTHAN GUM
- TRIETHANOLAMINE
- GLYCERIN
- CETYL ALCOHOL
- PROPYLENE GLYCOL
- POTASSIUM CETYL PHOSPHATE
- CAPRYLIC/CAPRIC TRIGLYCERIDE
- ARCTIUM LAPPA SEED OIL
- CAMELLIA SINENSIS LEAF OIL
- CHAMOMILE FLOWER OIL
- SALICYLIC ACID
- PHENOXYETHANOL
- MALTODEXTRIN
- ALOE BARBADENSIS LEAF JUICE
- C12-20 ALKYL GLUCOSIDE
- ALLANTOIN
- CALCIUM DISODIUM EDTA
- GLYCYRRHIZA GLABRA (LICORICE) ROOT
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 85424-017 | 85424-017-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| RoyceDerm Seborrheic Dermatitis and Psoriasis Treatment cream | SALICYLIC ACID 3% | RoyceDerm LLC | 4ac42528-9210-6936-e063-6294a90a4168 | 2026-02-14 | Warnings | 85424-017-01 85424-017 85424001701 4ac42528-9211-6936-e063-6294a90a4168 4ac42528-9210-6936-e063-6294a90a4168 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
